FDA Import Refusal 799-4231340-5/11/1 — ELI LILLY AND COMPANY
The FDA refused shipment 799-4231340-5/11/1 from ELI LILLY AND COMPANY (Australia) on Nov 29, 2024. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 29, 2024
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 61PCP74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 118,3280